IMR Press / RCM / Volume 23 / Issue 12 / DOI: 10.31083/j.rcm2312406
Open Access Systematic Review
Prognostic Value of Cardiac Magnetic Resonance in Assessing Right Ventricular Strain in Cardiovascular Disease: A Systematic Review and Meta-Analysis
Show Less
1 Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China
2 Discipline of Medical Radiation Science, Curtin Medical School, Curtin University, 6845 Perth, Western Australia, Australia
3 Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China
*Correspondence: z.sun@curtin.edu.au (Zhonghua Sun); leixu2001@hotmail.com (Lei Xu)
Academic Editors: Constantina Aggeli and Dimitrios Tsartsalis
Rev. Cardiovasc. Med. 2022, 23(12), 406; https://doi.org/10.31083/j.rcm2312406
Submitted: 1 June 2022 | Revised: 3 October 2022 | Accepted: 28 October 2022 | Published: 12 December 2022
(This article belongs to the Special Issue New Insight into Cardiac Strain Imaging)
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Objective: To evaluate the prognostic value of cardiac magnetic resonance (CMR) imaging in assessing right ventricular strain via meta-analysis of current literature. Background: Right ventricular strain recorded with CMR serves as a novel indicator to quantify myocardial deformation. Although several studies have reported the predictive value of right ventricular strain determined using CMR, their validity is limited by small sample size and low event number. Methods: Embase, Medline and Web of Science were searched for studies assessing the prognostic value of myocardial strain. The primary endpoint was a composite of all-cause mortality, cardiovascular death, aborted sudden cardiac death, heart transplantation and heart failure admissions. Results: A total of 14 studies met the selection criteria and were included in the analysis (n = 3239 adults). The random-effects model showed the association of parameters of right ventricular strain with major adverse cardiac events. Absolute value of right ventricular global longitudinal strain was negatively correlated with right ventricular ejection fraction (hazard ratio: 1.07, 95% confidence interval: 1.05–1.08; p = 0.013). Despite the small number of studies, right ventricular radial strain, right ventricular circumferential strain and right ventricular long-axis strain displayed potential prognostic value. Conclusions: Right ventricular strain measured with CMR is an effective prognostic indicator for cardiovascular disease.

Keywords
meta-analysis
strain
right ventricle
cardiac magnetic resonance
prognosis
1. Introduction

Right ventricular function has emerged as a crucial parameter in the early diagnosis and prognostic assessment of cardiovascular disease [1]. For example, this function has a potential predictive role in pulmonary hypertension (PH) with right ventricular involvement, advanced heart failure (HF) with biventricular involvement [2] and global heart involvement, such as myocardial amyloidosis, as well as in patients surgically treated for tetralogy of Fallot (TOF).

Cardiac magnetic resonance (CMR) is currently the gold standard for assessing right ventricular function [3]. Moreover, right ventricular strain analysis using CMR is one of the several methods for assessing right ventricle (RV) systolic function and detects both myocardial deformability and early abnormalities to provide independent prognostic information. Studies have demonstrated the significance of left ventricular strain in predicting the prognosis of cardiovascular disease [4, 5]. Recently, certain studies have established that RV strain is an independent prognostic factor for several cardiovascular diseases [1, 2]; however, its clinical significance is limited because of the small sample size and the small number of endpoint events. Hence, a systematic review and meta-analysis was conducted to evaluate the prognostic value of right ventricular strain in cardiovascular disease.

2. Materials and Methods
2.1 Search Strategy

This systematic review and meta-analysis was designed and conducted according to the PRISMA statement (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) [6] and the Cochrane Handbook for Systematic Reviews of Interventions [7]. Two reviewers (BKR and ZZ) systematically searched Embase, Medline and Web of Science databases for eligible studies on CMR strain in patients with cardiovascular diseases. This search was performed using three sets of keywords in combination. The first set included the terms ‘prognostic’ OR ‘prognosis’ OR ‘predictor’ OR ‘outcome’ OR ‘outcomes’. The second set included the terms ‘tissue tracking’ OR “feature tracking’ OR ‘strain’ OR ‘CMR-FT’. The third set included the terms ‘cardiac magnetic resonance’ OR ‘CMR’. The complete search strategy is presented in Supplementary Table 1. The results of randomized controlled trials, cohort studies and studies published in peer-reviewed journals were included, and the reference lists of these articles were carefully examined. This study was prospectively registered with the PROSPERO database of systematic reviews (Cardiac magnetic resonance right ventricular strain in predicting prognosis of patients with cardiovascular disease: A systematic review and meta-analysis CRD42021245484).

2.2 Inclusion and Exclusion Criteria and Endpoint

Those studies in which patients with cardiovascular disease underwent CMR to assess myocardial strain were included. At least one of the following outcome measures was used to assess prognosis: all-cause mortality, cardiovascular death, aborted sudden cardiac death, heart transplantation and HF admissions. Studies in which patients had undergone surgery or intervention, those that only investigated left heart or right atrial strain and those involving only ultrasound or nuclear medicine were excluded. Conference abstracts, case reports, editorials and commentaries were also excluded.

2.3 Study Selection and Quality Evaluation

Studies included in the meta-analysis were independently assessed by two reviewers. They independently reviewed all titles and abstracts and selected eligible articles based on the inclusion and exclusion criteria. Any disagreement was resolved via discussion and submission of the study report to a third reviewer (GYF). Full texts of eligible articles were reviewed.

The Newcastle–Ottawa scale (NOS) [8] was used to systematically evaluate the quality of studies. This scale assesses study quality based on three aspects: selection and definition of included populations (0–4 points), comparability of controlled studies (0–2 points) and determination of results (0–3 points).

2.4 Data Extraction

The same two researchers performed independent extraction and review; all disagreements were mutually discussed and resolved by consensus. The following information was extracted from each study: title; authors; publication year; study design type; number of patients; type of disease; clinical information; software used for strain analysis; key CMR results pertaining to the strain, namely, left ventricular ejection fraction (LVEF) and right ventricular ejection fraction (RVEF); and effect size estimation. Categorical data were expressed as percentages, and continuous variables were expressed as mean with standard deviation or median with interquartile range. Effect size estimates were used to extract hazard ratios (HRs) and their 95% confidence intervals (CIs), if available. For grouped data, mean and standard deviation of the groups were combined according to the formula specified by the Cochrane Collaboration.

By convention, negative strain values represent shortening; thus, a higher absolute value (more negative) for global longitudinal strain (GLS) is referred to as ‘better’ and a lower absolute value (less negative or closer to zero) as ‘worse’ [9]. To avoid variability in reporting and interpreting studies in this review, the percentage of GLS was used to indicate a negative sign. Similarly, the percentage of global circumferential strain (GCS) referred to a negative sign, and the percentage of global radial strain (GRS) referred to a positive sign.

2.5 Data Analysis

Pooled HRs and their 95% CIs were calculated for the parameters of RV longitudinal strain (RVGLS), RV circumferential strain (RVGCS), RV radial strain (RVGRS), LVEF and RVEF using the random-effects model to ensure consistency. Heterogeneity was assessed using the Cochrane test and discordance factor (I2). Sensitivity analyses were performed to assess the robustness of results by re-running the analysis, excluding one study at a time. Simultaneously, a meta-regression was performed for each risk factor to determine the possible factors associated with heterogeneity. STATA (version 16, ICI Stata Corporation, College Station, TX, USA) was used for statistical analysis with two-tailed p-values. A p-value of <0.05 was considered significant. Correlation analysis among RVGLS, RVEF and RVEDVi (end-diastolic volume index) was performed using STATA.

2.6 Patient and Public Involvement in the Study

It was not possible to involve either patients or the public in the design, conduct, reporting or dissemination plans of our research.

3. Results
3.1 Selection of Eligible Studies

A total of 2617 relevant abstracts of full-text articles were retrieved. These abstracts included 1005 duplicate articles; 680 articles that only involved left heart and right atrial strain and 180 articles in which prognosis was not covered were excluded. In addition, 205 reviews, abstracts, cases and editorials were excluded. Another 524 records were excluded as these involved animal experiments or comprised only ultrasound, nuclear medicine and surgical and interventional medical history. The remaining 23 articles were full-text reviews, of which 9 were excluded owing to the lack of our pre-specified results, thus leaving 14 articles for detailed analysis [2, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22]. The corresponding author of two studies [11, 13] was same; however, both were included because of differences in parameters, time of data collection and number of patients. The detailed flowchart of the search strategy is shown in Fig. 1.

Fig. 1.

Search strategy to identify eligible studies by searching databases.

3.2 Patient Characteristics

The study and patient characteristics are listed in Table 1 (Ref. [2, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22]). The information obtained from CMR is presented in Table 2 (Ref. [2, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22]). Our study included ten prospective studies [2, 10, 11, 12, 14, 15, 18, 19, 20, 21] and four retrospective studies [13, 16, 17, 22]. Strain values were calculated using CMR-FT post-processing software; however, the software used in each study varied. Of these, QStrain software (five studies [10, 11, 15, 18, 19]) and CVI42 software (six studies [2, 12, 13, 20, 21, 22]) were commonly used. The total number of subjects included in these 14 studies [2, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22] was 3239; their mean age was 58.9 years, and 67.5% were men. Of these, 37.5% had ischemic cardiomyopathy, 23.5% had dilated cardiomyopathy (DCM) or HF, 9.5% had hypertrophic cardiomyopathy, 8.6% had amyloidosis, 6.4% had PH, 4.0% had arrhythmogenic right ventricular cardiomyopathy (ARVC) and 10.5% had other heart diseases.

Table 1.Characteristics of eligible studies in the meta-analysis.
First author Year Design Median follow-up, years Population Available Population Endpoint Included in Analysis Age, years Male, % BMI Comorbidities, %Coronary artery disease Comorbidities, %Hypertension Comorbidities, %Diabetes Comorbidities, %Dyslipidemia NOS
predictive value for right ventricular strain: T Liu [2] 2020 prospective 1.6 192 DCM MACEs 53 ± 14 72.9 26 ± 5 NA 41.3 14.8 NA 8
Kazimierczyk [10] 2020 prospective 1.4 28 PH MACEs 50 ± 16 83.0 NA NA NA NA NA 5
Wan [11] 2020 prospective 3.1 129 AL Amyloidosis all-cause mortality 58 ± 11 61.2 22 ± 3 NA NA NA NA 6
Li [12] 2020 prospective 1.2 87 AL amyloidosis all-cause mortality 57 ± 9 64.4 NA NA NA NA NA 7
H Liu [13] 2019 retrospective 1.6 64 AL Amyloidosis all-cause mortality 58 ± 13 56.3 NA 0.0 1.6 3.1 NA 5
Houard [14] 2019 prospective 4.7 266 HF Overall death, CV death 60 ± 14 71.0 26 ± 5 51.0 46.0 24.0 NA 8
Vos [18] 2022 prospective 8.0 33 PH MACEs 58 (46–72) 24.0 NA NA NA NA NA 7
Cittar [20] 2021 prospective 1.6 273 NIDCM MACEs 51 (41–60) 66.0 NA NA 35.0 16.0 NA 6
Stiermaier [21] 2020 prospective 1.0 1235 STEMI/NSTEMI MACEs 64 (53–73) 74.9 NA 100.0 71.9 23.4 38.3 8
Yang [16] 2016 retrospective 1.2 364 Consecutive series MACEs 66 65.0 23 ± 3 28.0 58.0 22.0 0.4 6
Siqueira [17] 2016 retrospective 2.0 103 PH MACEs 52 ± 12 26.4 NA NA 21.8 10.9 15.5 7
No predictive value for right ventricular strain: Padervinskienė [15] 2019 prospective 2.5 43 PH MACEs 55 35.0 NA NA NA NA NA 7
Bourfiss [19] 2022 prospective 4.3 132 ARVC the occurrence of sustained VA following CMR 41 ± 16 43.0 NA NA NA NA NA 8
Mahmod [22] 2022 retrospective 4.4 290 HCM MACEs 52 ± 15 74% 28 ± 5 NA 30 78 NA 7
PH, Pulmonary hypertension; HF, heart failure; AL, amyloid light-chain; STEMI, ST-elevation myocardial infarction; NSTEMI, Non-ST-elevation myocardial infarction; DCM, Dilated cardiomyopathy; NIDCM, Non-ischemic dilated cardiomyopathy; ARVC, Arrhythmogenic right ventricular cardiomyopathy; HCM, Hypertrophic cardiomyopathy; CV, Cardiovascular; MACE, Major Adverse Cardiovascular Events; BMI, Body Mass Index; NOS, Newcastle-Ottawa Scale for quality assessment of non-randomized studies; values are mean ± SD (%).
Table 2.Information obtained from CMR in the studies.
First Author Vendor Software LVEF (%) Univariable analysis: HR, CI, p value RVEF (%) Univar able analysis: HR, CI, p value RVEDV Univariable analysis: HR, CI, p value RVEDVi Univariable analysis: HR, CI, p value Strain RVGLS Univariable analysis: HR, CI, p value Multivariable analysis: HR, CI, p value RVGRS Univariable analysis: HR, CI, p value RVGCS Univariable analysis: HR, CI, p value
predictive value for right ventricular strain T Liu [2] Siemens GE CVI42 software 22.4 ± 9.8 0.96 (0.91–1.02), p = 0.169 30.4 ± 14.1 0.99 (0.96–1.02) p = 0.686 133 ± 44 1.01 (1–1.02) p = 0.01 NA NA L/C –10.5 ± 5.2 1.14 (1.01–1.28) p = 0.035 1.17 (1.04–1.32) p = 0.01 NA NA –7.7 ± 3.8 1.05 (0.93–1.19) p = 0.456
Kazimierczyk [10] Siemens Qstrain software 60.3 ± 9.9 1.05 (0.96–1.15), p = 0.23 25.8 ± 13.6 0.88 (0.78–0.99) p = 0.03 NA NA 118.2 ± 21.7 1.01 (0.98–1.03) p = 0.48 L –16.2 ± 8.1 1.11 (1.01–1.31) p = 0.04 NA NA NA NA NA
Wan [11] Siemens Qstrain software 47.0 ± 15.0 0.98 (0.96–0.99), p < 0.001 47.0 ± 14.0 0.96 (0.95–0.98) p < 0.001 NA NA 68 ± 23 1.004 (0.995–1.013) p = 0.362 L –14.2 ± 7.0 1.10 (1.06–1.14) p < 0.001 1.07 (1.03–1.11) p = 0.001 NA NA NA NA
Li [12] Siemens CVI42 software 58.4 ± 10.7 0.94 (0.91–0.97), p < 0.001 57.2 ± 10.2 0.96 (0.93–0.99) p = 0.005 NA NA 63.3 ± 14.5 NA L/R/C –19.1 ± 6.3 1.18 (1.10–1.26) p < 0.001 1.10 (1.00–1.21) p = 0.047 22.4 ± 7.1 0.95 (0.90–1.00) p = 0.048 –13.3 ± 4.4 NA
H Liu [13] Siemens CVI42 software 52.2 ± 12.6 0.97 (0.95–0.99), p = 0.001 41.5 ± 9.9 0.99 (0.97–1.01) p = 0.097 NA NA 61.1 ± 20.5 NA L/R/C NA 1.12 (1.03–1.22) p = 0.006 1.02 (0.89–1.16) p = 0.776 NA 0.92 (0.88–0.96) p < 0.001 NA 1.02 (0.89–1.16) p = 0.776
Houard [14] Philips Segment version 2.2 23 ± 7 0.98 (0.90–1.01), p = 0.16 42.0 ± 15.0 0.98 (0.97–0.99) p = 0.03 NA NA 86 ± 33 NA L –11.8 ± 4.3 1.06 (1.01–1.11) p = 0.015 1.05 (0.99–1.10) p = 0.05 NA NA NA NA
Vos [18] Siemens Philips, GE Qstrain software 58.0 ± 9.0 NA 46.0 (38.0–53.0) 0.96 (0.92–1.01) p = 0.14 NA NA 101 (86–138) 1.01 (1–1.02) p = 0.01 L/C –20.0 ± 6.0 1.18 (1.04–1.34) p = 0.01 NA NA NA –12.0 ± 5.0 1.01 (0.91–1.13) p = 0.80
Cittar [20] Siemens Philips CVI42 software 34.0 (25.0–43.0) 1.08 (1.04–1.11), p < 0.001 51.0 (40.0–59.0) 1.05 (1.03–1.08), p < 0.001 NA NA NA 1.02 (1.1–1.03) p < 0.001 L/C/R –19.1 (–15.4 to –23.0) 1.06 (1.02–1.10) p = 0.001 NA 17.6 (12.0–23.7) NA 10.5 (–7.5 to –13.2) NA
Stiermaier [21] NA CVI42 software 50.6 (43.5–57.5) NA 61.3 (54.2–67.8) NA NA NA NA NA L –21.3 (–16.3 to 26.1) 1.07 (1.04–1.10) p < 0.001 NA NA NA NA NA
Yang [16] GE, Philips 2D Cardiac Performance Analysis 48.0 ± 20.0 0.96 (0.94–0.98), p < 0.0001 44.9 ± 11.3 0.94 (0.92–0.97) p < 0.0001 NA NA 66.4 (56.1–80.5) 1 (0.99–1.01) p = 0.085 L/R/C –18.3 ± 6.9 1.03 (0.98–1.09) p = 0.1708 NA 21.0 ± 8.0 0.92 (0.87–0.96) p = 0.0010 –12.2 ± 3.8 1.11 (1.01–1.23) p = 0.0253
Siqueira [17] Simens Philips 2D CPA MR 58.9 ± 9.8 NA, p < 0.001 42.2 ± 13.7 p < 0.001 NA NA 98.8 (75.3–127) NA L/C/ –15.9 ± 6.4 NA NA NA p = 0.001 –11.2 ± 4.9 p = 0.007
no predictive value for right ventricular strain: Padervinskienė [15] Siemens Qstrain software 56.0 ± 13.2 NA 38.2 ± 12.9 NA NA NA NA NA L NA NA NA NA NA NA NA
Bourfiss [19] Siemens Philips,GE Qstrain software 56.0 ± 8.0 NA NA NA NA 102 ± 30 NA L –22.5 ± 8.4 1.05 (1.00–1.11) p = 0.053 NA NA NA NA NA
Mahmod [22] Avanto and TIMTrio, Siemens GE cvi42 70.0 ± 6.0 NA 63.0 ± 7.0 1.07 (1.05–1.10) p < 0.001 52 ± 42 NA NA NA L –21.0 ± 5.0 1.03 (1.00–1.06) p = 0.096 NA 17.0 ± 7.0 NA –10.0 ± 4.0 NA
Values are mean ± SD (%); HR, Hazard ratio; CI, Confidence interval; LVEF, Left ventricular ejection fraction; RVEF, Right Ventricular Ejection Fraction; EDV, end-diastolic volume indexed; EDVi, end-diastolic volume indexed; RVGLS, right ventricle longitudinal strain; RVGCS, right ventricle circumferential strain; RVGRS, right ventricle radial strain.
3.3 Outcomes

The cut-off values of RVGLS obtained in five studies [2, 13, 17, 19, 20] were –8.5%, –17%, –15%, –19.1% and –22.5%. Univariable analysis was performed in twelve studies [2, 10, 11, 12, 13, 14, 16, 18, 19, 20, 21, 22] and multivariable analysis in five studies [2, 11, 12, 13, 14] on the prognostic value of RVGLS after adjusting for significant factors. In the univariate analysis, the pooled risk (HR) of RVGLS calculated using the random-effects model was 1.07 (95% CI: 1.05–1.08; p = 0.013). In other words, for each 1% decrease in RVGLS, the risk of major adverse cardiovascular event (MACE) occurrence increased by 7% (Fig. 2). Moderate heterogeneity was detected (I2 = 54%). In the multivariate analysis, the pooled risk (HR) of RVGLS estimated using the random-effects model was 1.07 (95% CI: 1.04–1.10; p = 0.48) (Fig. 2). There were three univariate analysis studies for RVGRS [12, 13, 16] and four [2, 13, 16, 18] for RVGCS. The relationship among RVGRS, RVGCS and MACE was analysed separately. The pooled risk (HR) of RVGRS was 0.93 (95% CI: 0.90–0.95; p = 0.479) and that of RVGCS was 1.05 (95% CI: 0.99–1.11; p = 0.595) in the random-effects model, with no heterogeneity (Fig. 2). Furthermore, the prognostic value of ejection fraction was determined in the included studies. The pooled risk (HR) was 0.98 (95% CI: 0.97–0.99; p < 0.001; I2 = 85.4%) for LVEF and 0.99 (95% CI: 0.98–0.99; p = 0.075; I2 = 91.4%) for RVEF (Fig. 3). Both were calculated using the random-effects model. However, in univariate analysis, the heterogeneity of LVEF and RVEF was clearly increased compared with RVGLS. Pearson’s correlation analysis showed a significantly negative correlation between RVEF and RVGLS (r = –0.721, p = 0.012; Fig. 4). However, there was no significant correlation between RVGLS and RVEDVi (r = –0.708, p = 0.075).

Fig. 2.

Relationship among RVGLS, RVGRS and RVGCS, as determined with univariable and multivariable analyses. RVGLS, RV longitudinal strain; RVGRS, RV radial strain; RVGCS, RV circumferential strain.

Fig. 3.

Comparison of the predictive values of RVGLS, LVEF and RVEF. RVGLS, RV longitudinal strain; LVEF, Left ventricular ejection fraction; RVEF, right ventricular ejection fraction.

Fig. 4.

Significant negative correlation of RVEF with RVGLS. RVEF, right ventricular ejection fraction; RVGLS, RV longitudinal strain.

In addition, two articles on the prognostic value of right ventricular long axis strain (RV-LAS) were retrieved to investigate its ability to assess prognosis in patients with hypertrophic cardiomyopathy (HCM) and non-ischemic dilated cardiomyopathy (NIDCM) [23, 24]. Because the number of articles was too small, the corresponding meta-analysis was not performed.

3.4 Publication Bias and Heterogeneity

Because of the small number of articles included in the meta-analysis, corresponding publication bias analysis was not performed. In the meta-regression analysis, 14 of the hypothesized confounding factors, such as publication year, follow-up time, age, sample size and gender, were observed to be associated with the variability of RVGLS (Supplementary Table 2). In addition, no confounding factors could significantly explain the heterogeneity of RVGLS. In sensitivity analysis, the articles were excluded one by one, which revealed that Yang et al.’s [16] and Mahmod et al.’s [22] studies exerted an immense negative impact on the combined HR results (Supplementary Fig. 1). A possible reason could be that Yang included consecutive patients in their CMR examinations. Moreover, specific diseases were not studied and distinguished, which resulted in a large heterogeneity. Mahmod et al. [22] defined composite cardiovascular events as non-sustained ventricular tachycardia (NSVT), stroke, HF hospitalisation and cardiovascular death. This definition might have affected the final conclusion because there were multiple outcome events. Furthermore, Mahmod et al. [22] demonstrated that strain in the right ventricle is of great value in predicting the development of NSVT. However, these studies [16, 22] were included in the meta-analysis because of the predictive value of right ventricular strain in its findings.

4. Discussion

This meta-analysis confirmed that RV strain is an important independent predictor of adverse outcomes in many cardiovascular diseases and that RVGLS assessed with CMR has significant prognostic significance in patients with various underlying cardiac abnormalities. In addition, RVGLS values decreased with decreasing RVEF values, which indicates a significant correlation between the two. Also, RVGRS and RVGCS appear to have good predictive value although the number of studies in this analysis is too small to confirm this finding. Finally, RV-LAS was observed to be a powerful predictor of cardiovascular disease development.

CMR has high temporal and spatial resolution, can perform gracilis imaging well and is the gold standard for right ventricular structural evaluation in clinical studies [3]. Two-dimensional echocardiography is the most widely used imaging modality in RV assessment; however, its main limitation is that the image quality depends on operator experience and subject characteristics. EF is the most commonly used and key index that shows systolic function in clinical practice. Nevertheless, EF reflects only global volume changes and cannot reflect alterations in myocardial regional motion or impaired early diastolic function. Myocardial strain technique is a non-invasive quantitative analysis of global and regional myocardial systolic and diastolic functions. Speckle tracking echocardiography (STE) is an accurate and simple method to assess myocardial strain. Park et al. [25] showed that RVGLS obtained via two-dimensional STE correlates well with RVEF and longitudinal strain obtained with CMR. Although STE is primarily a post-processing method, it requires a specific frame rate (50–70 frames/s) and high image quality during image acquisition [26]. Moreover, its wide applicability may be hindered by poor acoustic windows. CMR plays an important role in assessing myocardial strain processes; for example, GCS exhibits better repeatability when calculated using CMR [27].

Several methods are available for obtaining information on myocardial deformation using CMR, which are broadly divided into two categories. The first category requires additional scans and includes CMR tagging, displacement encoding with stimulated echoes (DENSE) and strain-encoded imaging (SENC). The second category is CMR Feature tracking (CMR-FT), which records myocardial strain by acquiring retrospective CMR cine images [27]. CMR tagging, a gold standard for measuring myocardial strain, works on the principle of superimposing magnetic tags (black lines and tags) orthogonally onto the myocardium at the beginning of the cine sequence. The deformation of these lines throughout the cardiac cycle is subsequently analysed [28]. Although it is the most effective CMR technique for assessing myocardial strain [29], its use is limited owing to label fading and low spatial resolution, which reduce its accuracy [28]. CMR tagging requires certain additional sequences, prolonged image acquisition and breath-hold time. Furthermore, it is insensitive to through-plane motion [30]. DENSE for displacement coding was first introduced in 1999 [31], and it is a technique for encoding tissue displacement into the phase of an image. DENSE possesses high temporal and spatial resolution as well as superior strain accuracy and reproducibility [32]. However, additional sequences cause prolonged scanning times, thereby limiting its clinical application. SENC was developed based on the concept of CMR tagging [33], thus enabling the quantification of local deformation of tissues. To calculate myocardial strain, SENC uses magnetized tags parallel to the image plane (rather than being orthogonal as in CMR tagging), which allows higher spatial resolution and, hence, better right ventricular endocardial delineation. Therefore, this technique is effective in quantifying the strain in the through-plane. Because T1 relaxation time leads to fading of the tag, SENC cannot be used to assess myocardial deformation throughout the cardiac cycle. CMR-FT is a simple and convenient new technique for determining myocardial deformation, which can quantitatively analyse the systolic and diastolic functions of the global and regional myocardium in a non-invasive manner. This technology uses post-processing software to delineate the relative motion and displacement of voxels on the endocardial and epicardial boundaries of the right ventricle during the cardiac cycle. Moreover, local or global strain and strain rate of the right ventricle are obtained in radial, circumferential and longitudinal directions. Currently, CMR-FT post-processing analysis can be accomplished with several commonly used commercial software, such as TomTec, Circle, Medis and Medviso. In the case of CVI42, RV myocardial strain is estimated by loading images from four-chamber and short-axis slices into the strain analysis module. In all series, endocardial and epicardial contours are manually delineated per slice at end-diastole. Global myocardial strain parameters are obtained automatically [34], while Fig. 5 shows the specific measurement method. However, because the strain is not derived from the full thickness of the myocardial tissue, CMR-FT may be associated with low accuracy and measurement variability. As additional breath-hold scanning sequences are not required and the reduced scanning time improves the imaging efficiency, CMR-FT is an attractive clinical method. Therefore, all our included studies utilized this method for strain analysis. Additionally, RV-LAS refers to the percentage change in length between the LV apical adventitial border and the midpoint of the line between tricuspid annulus at the end of systole and that at diastole. Long-axis strain (LAS) is a rapidly derived new parameter in CMR cine images, which can be evaluated online without additional software tools and has good clinical application value.

Fig. 5.

Three-dimensional FT global longitudinal strain (GLS), global radial strain (GRS) and global circumferential strain (GCS) of RV obtained using CVI42.

Unlike left ventricular measurements, the assessment of right ventricular function is challenging because right ventricular trabecular muscles are significantly more in number, right ventricular wall is significantly thinner and arrangement and movement of cardiomyocytes are different [35]. CMR can reveal the morphology and function of the heart and is the gold standard for assessing the complex geometry of RV. Right ventricular strain obtained using CMR is more sensitive than EF and has a high clinical value in assessing right ventricular myocardial damage in patients with subclinical myocardial damage. The method is also useful in risk stratification and in determining the therapeutic effect. Compared with conventional parameters of RV systolic function, such as RVEF, RV strain can detect subtle changes in RV function without significant wall motion abnormalities or reduced global RV systolic function. Such changes have significantly higher predictive values than conventional parameters. For example, Mahmod et al. [22] found that both RV and LV strain were impaired in patients with HCM despite normal LVEFd. A small decrease was observed in RVEF, but it was within the acceptable normal range. Moreover, Henning et al. [36] found that the percentage of normal myocardium in LV and RV detected using rapid SENC (normal LV and RV myocardial segmental strain –17%) better identifies asymptomatic patients with subclinical LV dysfunction. This technique may be useful in the early identification of healthy subjects who may be at risk for HF as well as in the monitoring of LV and RV deformation during pharmacological interventions in future studies. RV strain can help in detecting the subclinical stage of PH and in assessing the disease and the associated prognosis [17]. In congenital heart diseases, such as TOF, CMR can assess the efficacy and necessity of surgery. Moon et al. [37] used CMR-FT and found that right ventricular strain values were significantly lower in the TOF group than in the normal group and that right ventricular longitudinal strain was closely related to adverse outcomes in patients with TOF. Early diagnosis and analysis of wall motion abnormalities are possible in patients with ARVC [38]. CMR-FT strain analysis helps to objectively quantify global/regional right ventricular dysfunction and dyssynchrony in patients with ARVC and provides effective diagnostic information.

The cut-off values of RVGLS were obtained in five studies [2, 13, 17, 19, 20]. Although the strain decreased compared with the normal group, the five values were significantly different. This variation could be attributed to the fact that the sources of patients differed in the five included studies [2, 13, 17, 19, 20]. The study by Liu et al. [2] only included patients with HF in stages C and D of cardiac function; hence, RVGLS was relatively worse.

RV fibres are primarily arranged along the longitudinal axis under the epicardium. In healthy individuals, longitudinal shortening largely leads to RV shortening [39]. Twelve studies [2, 10, 11, 12, 13, 14, 16, 18, 19, 20, 21, 22] on RVGLS were included in our meta-analysis, and despite the presence of moderate heterogeneity, the pooled effect values demonstrated the prognostic value of RVGLS. Of these, three articles concluded that right ventricular strain did not have a statistically significant prognostic value in cardiovascular disease. The following could be the reasons for this conclusion: Yang et al. [16] consecutively included patients with CMR findings and did not classify the disease specifically; hence the heterogeneity was relatively high. Bourfiss et al. [19] found that RV and LV strain were no longer significant predictors of persistent ventricular arrhythmias (VA) after adjusting for risk factors, such as RVEF and LVEF. The reason could be that most patients who developed VA already had advanced structural disease, but decreased RV longitudinal and LV circumferential strain were observed in other patients with ARVC and persistent VA during follow-up, thus indicating that strain can reflect changes in ventricular function. Although Mahmod et al. [22] noted that the decrease in RVGLS was not associated with cardiovascular composite events, it had a significant predictive value for the occurrence of non-sustained ventricular tachycardia. Several patients in the included studies had right heart involvement and global involvement, but a certain bias existed. Hence, the additional independent prognostic value of right ventricular strain must be carefully studied while considering conventional cardiac function. In four other studies [2, 13, 16, 18] that included RVGCS, it was shown to have good prognostic ability. However, more research on RVGRS and RVGCS is required because of the small number of available studies. In three studies [12, 16, 20], RVGRS exhibited good predictive power, possibly because strict motion of the basal RV and the thin atrioventricular free wall hindered adequate endocardial tracking on long-axis views [16]. The contribution of circumferential strain is important in patients with PH. Unfortunately, data on RVGCS were not included in the three studies [12, 16, 20] on PH, and thus, the results could not be validated. Yang et al. [23] showed that the predictive ability of RV-LAS was better than that of RVEF and TAPSE for the poor prognosis of patients with HCM. Arenja et al. [24] showed that RV-LAS had the highest diagnostic accuracy in the cohort of patients with NIDCM. Moreover, RV-LAS was an independent marker of MACEs in multivariate analysis. The above studies assert the important role of RV-LAS in prognosis prediction. RV-LAS is defined as the change in length from the LV apex to the tricuspid annulus rather than the RV apex; therefore, it may incorporate both LV and RV longitudinal functions. With the increase in studies on RV-LAS, in the future, the predictive value of RV-LAS can be proved using a meta-analysis.

This systematic review and meta-analysis has certain limitations. First, because studies on right ventricular strain are currently in the developmental stage, the number of studies included in this meta-analysis is relatively small (n = 14). Therefore, publication bias could not be explored. Moreover, only five studies [2, 13, 17, 19, 20] included cut-off values and they dealt with different diseases; hence, a pooled effect size and cut-off value could not be calculated for a specific disease. We are hopeful that with the increase in the number of in-depth studies in this field, we would be able to update and include more studies in the future to provide robust evidence. Furthermore, we believe that we would have a better understanding of the prognostic value of RVGRS and RVGCS. Second, as with meta-analyses of several observational studies, moderate heterogeneity exists among the articles because of differences in the study design, inclusion criteria, follow-up time and vendor software. Although we performed a correlative meta-regression analysis for some measures, we were unable to perform a meta-regression analysis due to the diverse variety of software vendors for the articles we included. it is not well understood whether differences in software suppliers are the source of heterogeneity. Our study demonstrated a significant negative correlation between RVGLS and RVEF. These conclusions have been confirmed in several studies [40, 41]. We understand that strain values may be affected by factors such as magnetic fields and post-processing software. With the increase in the studies on right ventricular strain, in the future, we can analyse the above factors in subgroups. Finally, to reduce the heterogeneity of articles, we excluded studies involving patients with a history of cardiac surgery. Strain is a valuable prognostic indicator for patients with congenital heart disease [42]. With continued technological advancements, a meta-analysis of these patients can be performed in the future.

5. Conclusions

This systematic review and meta-analysis establishes the prognostic value of right ventricular strain determined using CMR in cardiovascular disease. RVGLS assessed with CMR has significant prognostic implications in patients with different underlying cardiac abnormalities. RVGRS, RVGCS and RV-LAS appear to show good prognostic value, and although the number of studies on these strains is small, they can pave way for future studies and thus validate our conclusions. In the future, the prognostic value of right ventricular strain in different diseases can be investigated to obtain cut-off values that correspond to different diseases, thereby guiding treatment decisions and prognostic stratification.

Author Contributions

KB, LX and ZHS are guarantors of the integrity of the entire study; KB and ZZ were responsible for the screening of the literature, extraction of the data; HW and YFG was responsible for the analysis of the data; All results were checked by HKZ and TL; KB prepared the first draft of the manuscript, which was critically revised by LX and ZHS.

Ethics Approval and Consent to Participate

Not applicable.

Acknowledgment

Not applicable.

Funding

This study was supported by grants from the National Natural Science Foundation of China (U1908211, 82271986), the Capital’s Funds for Health Improvement and Research Foundation of China (2020-1-1052).

Conflict of Interest

The authors declare no conflict of interest. Zhonghua Sun is serving as one of the Editorial Board members and Guest Editors of this journal. Tong Liu is serving as one of the Guest Editors of this journal. We declare that Zhonghua Sun and Tong Liu had no involvement in the peer review of this article and have no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Dimitrios Tsartsalis and Constantina Aggeli.

References
[1]
Kanagala P, Arnold JR, Singh A, Khan JN, Gulsin GS, Gupta P, et al. Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction. The International Journal of Cardiovascular Imaging. 2021; 37: 255–266.
[2]
Liu T, Gao Y, Wang H, Zhou Z, Wang R, Chang S, et al. Association between right ventricular strain and outcomes in patients with dilated cardiomyopathy. Heart. 2021; 107: 1233–1239.
[3]
Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update. Journal of Cardiovascular Magnetic Resonance. 2020; 22: 19.
[4]
Fischer K, Obrist SJ, Erne SA, Stark AW, Marggraf M, Kaneko K, et al. Feature Tracking Myocardial Strain Incrementally Improves Prognostication in Myocarditis beyond Traditional CMR Imaging Features. JACC: Cardiovascular Imaging. 2020; 13: 1891–1901.
[5]
Holzknecht M, Reindl M, Tiller C, Reinstadler SJ, Lechner I, Pamminger M, et al. Global longitudinal strain improves risk assessment after ST-segment elevation myocardial infarction: a comparative prognostic evaluation of left ventricular functional parameters. Clinical Research in Cardiology. 2021; 110: 1599–1611.
[6]
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. British Medical Journal. 2016; 354: i4086.
[7]
Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database of Systematic Reviews. 2019; 10: Ed000142.
[8]
Margulis AV, Pladevall M, Riera-Guardia N, Varas-Lorenzo C, Hazell L, Berkman ND, et al. Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank. Clinical Epidemiology. 2014; 6: 359–368.
[9]
Tower-Rader A, Mohananey D, To A, Lever HM, Popovic ZB, Desai MY. Prognostic Value of Global Longitudinal Strain in Hypertrophic Cardiomyopathy: A Systematic Review of Existing Literature. JACC: Cardiovascular Imaging. 2019; 12: 1930–1942.
[10]
Kazimierczyk R, Małek ŁA, Szumowski P, Błaszczak P, Jurgilewicz D, Hładuński M, et al. Prognostic value of late gadolinium enhancement mass index in patients with pulmonary arterial hypertension. Advances in Medical Sciences. 2021; 66: 28–34.
[11]
Wan K, Lin J, Guo X, Song R, Wang J, Xu Y, et al. Prognostic Value of Right Ventricular Dysfunction in Patients With AL Amyloidosis: Comparison of Different Techniques by Cardiac Magnetic Resonance. Journal of Magnetic Resonance Imaging. 2020; 52: 1441–1448.
[12]
Li X, Li J, Lin L, Shen K, Tian Z, Sun J, et al. Left and right ventricular myocardial deformation and late gadolinium enhancement: incremental prognostic value in amyloid light-chain amyloidosis. Cardiovascular Diagnosis and Therapy. 2020; 10: 470–480.
[13]
Liu H, Fu H, Guo Y, Yang Z, Xu H, Shuai X, et al. The prognostic value of right ventricular deformation derived from cardiac magnetic resonance tissue tracking for all-cause mortality in light-chain amyloidosis patients. Cardiovascular Diagnosis and Therapy. 2020; 10: 161–172.
[14]
Houard L, Benaets M, de Meester de Ravenstein C, Rousseau MF, Ahn SA, Amzulescu M, et al. Additional Prognostic Value of 2D Right Ventricular Speckle-Tracking Strain for Prediction of Survival in Heart Failure and Reduced Ejection Fraction: A Comparative Study With Cardiac Magnetic Resonance. JACC: Cardiovascular Imaging. 2019; 12: 2373–2385.
[15]
Padervinskienė L, Krivickienė A, Hoppenot D, Miliauskas S, Basevičius A, Nedzelskienė I, et al. Prognostic Value of Left Ventricular Function and Mechanics in Pulmonary Hypertension: A Pilot Cardiovascular Magnetic Resonance Feature Tracking Study. Medicina. 2019; 55: 73.
[16]
Yang LT, Yamashita E, Nagata Y, Kado Y, Oshima S, Otsuji Y, et al. Prognostic value of biventricular mechanical parameters assessed using cardiac magnetic resonance feature-tracking analysis to predict future cardiac events. Journal of Magnetic Resonance Imaging. 2017; 45: 1034–1045.
[17]
de Siqueira MEM, Pozo E, Fernandes VR, Sengupta PP, Modesto K, Gupta SS, et al. Characterization and clinical significance of right ventricular mechanics in pulmonary hypertension evaluated with cardiovascular magnetic resonance feature tracking. Journal of Cardiovascular Magnetic Resonance. 2016; 18: 39.
[18]
Vos JL, Leiner T, van Dijk APJ, van der Zwaan HB, Sieswerda GT, Snijder RJ, et al. Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertension. The International Journal of Cardiovascular Imaging. 2022. (online ahead of print)
[19]
Bourfiss M, Prakken NHJ, James CA, Planken RN, Boekholdt SM, Ahmetagic D, et al. Prognostic value of strain by feature-tracking cardiac magnetic resonance in arrhythmogenic right ventricular cardiomyopathy. European Heart Journal - Cardiovascular Imaging. 2022. (online ahead of print)
[20]
Cittar M, Cipriani A, Merlo M, Vitrella G, Masè M, Carrer A, et al. Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy. Frontiers in Cardiovascular Medicine. 2021; 8: 765274.
[21]
Stiermaier T, Backhaus SJ, Matz J, Koschalka A, Kowallick J, de Waha-Thiele S, et al. Frequency and prognostic impact of right ventricular involvement in acute myocardial infarction. Heart. 2020; 107: 563–570.
[22]
Mahmod M, Raman B, Chan K, Sivalokanathan S, Smillie RW, Samat AHA, et al. Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy. Journal of Cardiovascular Magnetic Resonance. 2022; 24: 36.
[23]
Yang F, Wang J, Li Y, Li W, Xu Y, Wan K, et al. The prognostic value of biventricular long axis strain using standard cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy. International Journal of Cardiology. 2019; 294: 43–49.
[24]
Arenja N, Riffel JH, Halder M, Djiokou CN, Fritz T, Andre F, et al. The prognostic value of right ventricular long axis strain in non-ischaemic dilated cardiomyopathies using standard cardiac magnetic resonance imaging. European Radiology. 2017; 27: 3913–3923.
[25]
Park J, Kusunose K, Motoki H, Kwon DH, Grimm RA, Griffin BP, et al. Assessment of Right Ventricular Longitudinal Strain in Patients with Ischemic Cardiomyopathy: Head-to-Head Comparison between Two-Dimensional Speckle-Based Strain and Velocity Vector Imaging Using Volumetric Assessment by Cardiac Magnetic Resonance as a ”Gold Standard”. Echocardiography. 2015; 32: 956–965.
[26]
Marwick TH, Leano RL, Brown J, Sun J, Hoffmann R, Lysyansky P, et al. Myocardial Strain Measurement with 2-Dimensional Speckle-Tracking Echocardiography: definition of normal range. JACC: Cardiovascular Imaging. 2009; 2: 80–84.
[27]
Scatteia A, Baritussio A, Bucciarelli-Ducci C. Strain imaging using cardiac magnetic resonance. Heart Failure Reviews. 2017; 22: 465–476.
[28]
Jeung M, Germain P, Croisille P, ghannudi SE, Roy C, Gangi A. Myocardial Tagging with MR Imaging: Overview of Normal and Pathologic Findings. RadioGraphics. 2012; 32: 1381–1398.
[29]
Moore CC, McVeigh ER, Zerhouni EA. Quantitative Tagged Magnetic Resonance Imaging of the Normal Human Left Ventricle. Topics in Magnetic Resonance Imaging. 2000; 11: 359–371.
[30]
Augustine D, Lewandowski AJ, Lazdam M, Rai A, Francis J, Myerson S, et al. Global and regional left ventricular myocardial deformation measures by magnetic resonance feature tracking in healthy volunteers: comparison with tagging and relevance of gender. Journal of Cardiovascular Magnetic Resonance. 2013; 15: 8.
[31]
Aletras AH, Ding S, Balaban RS, Wen H. DENSE: Displacement Encoding with Stimulated Echoes in Cardiac Functional MRI. Journal of Magnetic Resonance. 1999; 137: 247–252.
[32]
Lin K, Meng L, Collins JD, Chowdhary V, Markl M, Carr JC. Reproducibility of cine displacement encoding with stimulated echoes (DENSE) in human subjects. Magnetic Resonance Imaging. 2017; 35: 148–153.
[33]
Vo HQ, Marwick TH, Negishi K. MRI-Derived Myocardial Strain Measures in Normal Subjects. JACC: Cardiovascular Imaging. 2018; 11: 196–205.
[34]
Xia H, Yeung DF, Di Stefano C, Cha SS, Pellikka PA, Ye Z, et al. Ventricular strain analysis in patients with no structural heart disease using a vendor-independent speckle-tracking software. BMC Cardiovascular Disorders. 2020; 20: 274.
[35]
Gulati A, Ismail TF, Jabbour A, Alpendurada F, Guha K, Ismail NA, et al. The Prevalence and Prognostic Significance of Right Ventricular Systolic Dysfunction in Nonischemic Dilated Cardiomyopathy. Circulation. 2013; 128: 1623–1633.
[36]
Steen H, Giusca S, Montenbruck M, Patel AR, Pieske B, Florian A, et al. Left and right ventricular strain using fast strain-encoded cardiovascular magnetic resonance for the diagnostic classification of patients with chronic non-ischemic heart failure due to dilated, hypertrophic cardiomyopathy or cardiac amyloidosis. Journal of Cardiovascular Magnetic Resonance. 2021; 23: 45.
[37]
Moon TJ, Choueiter N, Geva T, Valente AM, Gauvreau K, Harrild DM. Relation of Biventricular Strain and Dyssynchrony in Repaired Tetralogy of Fallot Measured by Cardiac Magnetic Resonance to Death and Sustained Ventricular Tachycardia. The American Journal of Cardiology. 2015; 115: 676–680.
[38]
Taha K, Bourfiss M, te Riele ASJM, Cramer MM, van der Heijden JF, Asselbergs FW, et al. A head-to-head comparison of speckle tracking echocardiography and feature tracking cardiovascular magnetic resonance imaging in right ventricular deformation. European Heart Journal - Cardiovascular Imaging. 2021; 22: 950–958.
[39]
Fayad ZA, Ferrari VA, Kraitchman DL, Young AA, Palevsky HI, Bloomgarden DC, et al. Right ventricular regional function using MR tagging: Normals versus chronic pulmonary hypertension. Magnetic Resonance in Medicine. 1998; 39: 116–123.
[40]
Kavurt AV, Paç FA, Koca S, Mutlu Mıhçıoğlu A, Yiğit H. The evaluation of right ventricular systolic function in patients with repaired Tetralogy of Fallot by conventional echocardiographic methods and speckle tracking echocardiography: Compared with the gold standard cardiac mangenetic resonance. Echocardiography. 2019; 36: 2251–2258.
[41]
Lu KJ, Chen JXC, Profitis K, Kearney LG, DeSilva D, Smith G, et al. Right Ventricular Global Longitudinal Strain is an Independent Predictor of Right Ventricular Function: a Multimodality Study of Cardiac Magnetic Resonance Imaging, Real Time Three-Dimensional Echocardiography and Speckle Tracking Echocardiography. Echocardiography. 2015; 32: 966–974.
[42]
Li VW, Yu CK, So EK, Wong WH, Cheung YF. Cheung, Ventricular Myocardial Deformation Imaging of Patients with Repaired Tetralogy of Fallot. The Journal of the American Society of Echocardiography. 2020; 33: 788–801.
Share
Back to top